US Patent Issued to NEURODAWN PHARMACEUTICAL on Sept. 29 for "Use of composition containing cilostazol in cerebrovascular diseases" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,234, issued on Sept. 29, was assigned to NEURODAWN PHARMACEUTICAL Co. LTD. (Nanjing, China).

"Use of composition containing cilostazol in cerebrovascular diseases" was invented by Yao Hua (Nanjing, China), Lei Wang (Nanjing, China), Zhengping Zhang (Nanjing, China), Rong Chen (Nanjing, China) and Shibao Yang (Nanjing, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is the use of a composition containing cilostazol or a pharmaceutically acceptable salt thereof and edaravone in the preparation of a drug for treating cerebrovascular diseases, especially ischemic cerebrovascular diseases. The experiment result shows that the tail vein ad...